期刊文献+

药物的眼表损害 被引量:6

Ocular surface damages associated with drugs
下载PDF
导出
摘要 众所周知,滴眼液可以直接接触并影响眼表组织,而一些针对其他部位的局部或全身用药也会通过不同机制对眼表产生毒性作用。常见眼表毒性的临床表现有视物模糊、痒感、干眼、溢泪等,但不同药物的眼表毒性却大相径庭。本文对临床常用药物诱发或导致的眼表毒性表现、可能的发病机制及治疗原则做一综述。 It is well known that eye drops in direct contact with ocular surface can affect the structure, while ocular surface damages may occur from local or systemic medications in the other parts of the body by different mechanisms. The clinical manifestations of the common ocular surface damages include blurred vision, itch, dry eye syndrome,epiphora, etc., however, the ocular surface damages of various medications are entirely alien from each other. The manifestations of ocular surface damages induced or caused by clinical frequently used drugs, possible pathogenesis and the principle of treatment were reviewed in this article.
出处 《中国中医眼科杂志》 2014年第4期304-308,共5页 China Journal of Chinese Ophthalmology
基金 黑龙江省教育厅科学技术研究(重点)项目(12521z020)
关键词 眼表 角膜毒性 结膜炎 药理学 副作用 ocular surface corneal damage conjunctivitis pharmacology side effect
  • 相关文献

参考文献45

  • 1Mingli Qu, Yao Wang, Lingling Yang, et al. Different cellular effects of four anti-inflammatory eye drops on human corneal epithelial cells:independent in active components[J]. Molecular Vision,2011, 17:3147-3155.
  • 2Seitz B,Hayashi S,Wee WR,et al. In vitro effects of aminoglyco- sides and fluoroquinolones on keratoeytes[J]. Invest Ophthalmol Vis Sci, 1996,37 (4) : 656-665.
  • 3Reviglio VE ,Hakim MA ,Song JK,et al. Effect of topical fluoro- quinolones on the expression of matrix metalloproteinases in the cornea[J]. BMC Ophthalmol, 2003,3 (10) : 10.
  • 4Sosa AB ,Epstein SP,Asbell PA. Evaluation of Toxicity of Commer- cial Ophthalmic Fluoroquinolone Antibiotics as Assessed on Immor- talized Corneal and Conjunctival Epithelial Cells[J]. Cornea 2008, 27(8) :930-934.
  • 5Sudesh S, Laibson PR. The impact of the herpetic eye disease stud- ies on the management of herpes simplex virus ocular infections [J]. Curr Opin Ophthalmol, 1999,10(4) :230-233.
  • 6Fraunfelder FW. Corneal Toxicity From Topical Ocular and Systemic Medications[J]. Cornea, 2006,25 (10) : 1133-1138.
  • 7Sehlotzer-Sehrehardt U,Zagorski Z,Holbaeh LM, et al. Corneal stro- mal calcification after topical steroid-phosphate therapy[J]. Arch Ophthalmol 1999,117 (10) : 1414-1418.
  • 8Fogla R, Rao SK, Biswas J. Avoiding conjunetival necrosis after pe- rioeular depot eortieosteroid injection[J], J Cataract Refract Surg,2000, 26(2) : 163-164.
  • 9Liu X,Wang S,Kao AA,et al. The Effect of Topical Pranoprofen 0.1% on the Clinical Evaluation and Conjunctival HLA-DR Ex- pression in Dry Eyes[J]. Cornea, 2012,31 ( 11 ) : 1235-1239.
  • 10Lindstrom R. The pharmacologic and pathophysiologie rationale for using NSAIDs in ocular inflammatory disease and ocular surgery[J]. Int Ophthalmol Clin, 2006,46 (4) : 7-11.

同被引文献65

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部